Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting infectious diseases. It serves as a building block for inhibitors of bacterial and parasitic enzymes due to its nitroheterocyclic structure, which can undergo redox activation in anaerobic environments. Commonly employed in the development of antitubercular and antiparasitic agents. Also utilized in medicinal chemistry research to construct libraries of imidazopyridine derivatives for screening against various disease targets.